Quoin Pharmaceuticals, Ltd.
For the period ended Aug 20, 2026. Filed Jul 16, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Aug 20, 2026 · Filed Jul 16, 2026
Contents
PROXY STATEMENT SUMMARY
PROXY STATEMENT
FOR THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON THURSDAY, AUGUST 20, 2026
PROXY STATEMENT SUMMARY
This summary highlights information contained elsewhere in this proxy statement. It does not contain all of the information you should consider, and you should read the entire proxy statement carefully before voting. References in this proxy statement to the “Company,” “Quoin,” “Quoin Ltd.,” “we,” “us,” and “our” refer to Quoin Pharmaceuticals Ltd., an Israeli company. The Notice of Annual General Meeting of Shareholders, proxy statement and a proxy card or voting instruction form, as applicable, are being distributed and made available to the holders of our ordinary shares, as well as holders of our ordinary shares that are represented by American Depositary Shares (“ADSs”), collectively referred to as “shareholders,” starting on or about July 16, 2026. Our principal executive offices are located at 42127 Pleasant Forest Ct., Ashburn, VA 20148.
Annual Meeting Information
| | Date and Time: | | | Thursday, August 20, 2026, beginning at 12:00 p.m., US Eastern Time | |
|---|---|---|---|---|---|
| | Meeting Place: | | | Offices of Blank Rome LLP located at One Logan Square, Philadelphia, PA 19103 | |
| | Record Date: | | | July 15, 2026 | |
| | Voting: | | | Each ordinary share is entitled to one vote per share on all matters presented at the Annual Meeting. Each ADS represents thirty-five of our ordinary shares. | |
It is important that your shares be represented and voted at the Annual Meeting. Shareholders should vote by marking, signing and dating the accompanying proxy card, and returning it promptly. If your ADSs are held in an account at a bank, broker or other nominee, please check the materials provided to you by your broker, bank or other nominee to determine how you may vote your ADSs.
Voting Matters and the Board’s Recommendation
| Agenda Item | | | Board Vote Recommendation | | | Page Reference | |
|---|---|---|---|---|---|---|---|
| Election of seven directors | | | FOR each Director Nominee | | | 7 | |
| Approval, by an advisory vote, of the compensation of our named executive officers | | | FOR | | | 24 | |
| Approval of changes to our non-employee directors’ compensation program | | | FOR | | | 25 | |
| Approval of changes to the matching contributions payable pursuant to the Company’s 401(k) plan, including to the Company’s U.S.-based executive officers | | | FOR | | | 26 | |
| Appointment of CBIZ CPAs P.C. to serve as our independent registered public accounting firm until our next annual general meeting of shareholders | | | FOR | | | 27 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.